Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
GLS protein | 7 | 0 | 0 | 7 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
Smad3 | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
progesterone receptor | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 4 | 3 | 0 | 7 |
ATP-binding cassette sub-family C member 3 | 0 | 16 | 0 | 16 |
Multidrug resistance-associated protein 4 | 0 | 16 | 0 | 16 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 12 | 0 | 6 | 1 | 11 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Bile salt export pump | 0 | 18 | 0 | 18 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 7 | 1 | 14 |
Carbonic anhydrase 2 | 0 | 7 | 3 | 15 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 6 | 1 | 9 |
Cytochrome P450 3A4 | 0 | 7 | 0 | 7 |
Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 3 | 0 | 7 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 3 | 1 | 8 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 3 | 0 | 7 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 6 | 1 | 10 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 6 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 3 | 0 | 7 |
Carbonic anhydrase 5A, mitochondrial | 0 | 6 | 3 | 13 |
Prostaglandin G/H synthase 2 | 0 | 2 | 1 | 4 |
Carbonic anhydrase 7 | 0 | 6 | 1 | 10 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 3 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 3 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 3 | 1 | 8 |
Carbonic anhydrase 9 | 0 | 6 | 1 | 11 |
GABA theta subunit | 4 | 3 | 0 | 7 |
Canalicular multispecific organic anion transporter 1 | 0 | 16 | 0 | 16 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 13 | 0 | 4 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 4 | 3 | 0 | 7 |
Carbonic anhydrase 14 | 0 | 6 | 1 | 11 |
Carbonic anhydrase 5B, mitochondrial | 0 | 6 | 1 | 11 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
thioredoxin reductase | 10 | 0 | 0 | 10 |
GALC protein | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
arylsulfatase A | 4 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
geminin | 13 | 0 | 0 | 13 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Prolyl endopeptidase | 0 | 3 | 0 | 3 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 3 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
Cathepsin B | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 5 | 0 | 5 |
Translocator protein | 0 | 2 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 5 | 0 | 5 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 6 | 1 | 7 |
Cholinesterase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 4 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 4 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Delta carbonic anhydrase | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 5 | 1 | 7 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
TDP1 protein | 11 | 0 | 0 | 11 |
G | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
IDH1 | 5 | 0 | 0 | 5 |
NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 3 | 2 | 5 |
Interferon beta | 8 | 0 | 0 | 8 |
HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
ATP-dependent translocase ABCB1 | 0 | 6 | 1 | 14 |
Alpha-2A adrenergic receptor | 0 | 13 | 1 | 14 |
Alpha-2C adrenergic receptor | 0 | 9 | 1 | 10 |
Alpha-2B adrenergic receptor | 0 | 3 | 2 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 3 | 2 | 5 |
Alpha-2A adrenergic receptor | 0 | 3 | 2 | 5 |
Alpha-1D adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-1A adrenergic receptor | 0 | 3 | 2 | 5 |
Alpha-1B adrenergic receptor | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 10 | 0 | 10 |
Spike glycoprotein | 8 | 0 | 0 | 8 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 1 | 5 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
Genome polyprotein | 0 | 1 | 1 | 2 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
AR protein | 10 | 0 | 0 | 10 |
regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
polyprotein | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 7 | 0 | 0 | 7 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 1 | 5 |
D(2) dopamine receptor | 0 | 7 | 1 | 8 |
Alpha-2B adrenergic receptor | 0 | 9 | 0 | 9 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 10 | 1 | 11 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 4 |
D(1A) dopamine receptor | 0 | 6 | 0 | 6 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 12 | 1 | 13 |
5-hydroxytryptamine receptor 2C | 0 | 11 | 1 | 12 |
5-hydroxytryptamine receptor 1B | 0 | 10 | 0 | 10 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 10 | 0 | 10 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 13 | 1 | 14 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 5 | 0 | 0 | 5 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
acetylcholinesterase | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
Vpr | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
Albumin | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 2 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 5 | 0 | 7 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
Sodium channel protein type 9 subunit alpha | 0 | 6 | 0 | 6 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 1 | 0 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 4 | 1 | 5 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 3 | 7 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 2 | 5 |
Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 0 | 1 | 1 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 0 | 1 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
67.9K protein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
Parkin | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 2 | 3 |
Procathepsin L | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 5 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 3 | 0 | 0 | 3 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 1 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 1 | 3 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
pregnane X receptor | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Carboxypeptidase M | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 4 | 1 | 6 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |